Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Biomedical innovation solves all sustainability warrants---that’s a defense of our methodology and a disad to theirs.

Michael Chui 20. Partner at the McKinsey Global Institute (MGI), McKinsey's business and economics research arm. James Irvine Foundation and the Asia Society of Northern California, and a member of the Council on Foreign Relations. “The Bio Revolution Innovations transforming economies, societies, and our lives.” https://www.mckinsey.com/~/media/McKinsey/Industries/Pharmaceuticals%20and%20Medical%20Products/Our%20Insights/The%20Bio%20Revolution%20Innovations%20transforming%20economies%20societies%20and%20our%20lives/MGI-Bio-Revolution-Report-May-2020.ashx.

New biological capabilities have the potential to bring sweeping change to economies and societies. The effects will be felt across value chains, from how R&D is conducted to the physical inputs in manufacturing to the way medicines and consumer products are delivered and consumed. These capabilities include the following: — Biological means could be used to produce a large share of the global economy’s physical materials, potentially with improved performance and sustainability. Significant potential exists to improve the characteristics of materials, reduce the emissions profile of manufacturing and processing, and shorten value chains. Fermentation, for centuries used to make bread and brew beer, is now being used to create fabrics such as artificial spider silk. Biology is increasingly being used to create novel materials that can raise quality, introduce entirely new capabilities, be biodegradable, and be produced in a way that generates significantly less carbon emissions. Mushroom roots rather than animal hide can be used to make leather.11 Plastics can be made with yeast instead of petrochemicals. — Increased control and precision in methodology is occurring across the value chain, from delivery to development and consumption with more personalization. Advances in biological sciences have made R&D and delivery processes more precise and predictable; the character of R&D is shifting from discovery by accident to rational design. Increasing knowledge of human genomes and the links between certain genes and diseases is enabling the spread of personalized or precision medicine, which can be more effective than the one-size-fits-all therapies of the past.12 Precision also applies to agriculture, where insights from a plant or soil’s microbiome increasingly can be used to optimize yield as well as to offer consumers with, for instance, personalized nutrition plans based on genetic tests.13 — The capability to engineer and reprogram human and nonhuman organisms is increasing. Gene therapies could offer complete cures of some diseases for the first time. The same technical advances that are driving capabilities that improve human health can be used to introduce valuable new traits that, for instance, improve the output or yield of nonhuman organisms like microbes, plants, and animals. Crops can be genetically engineered to produce higher yields and be more heat- or drought-resistant, for instance. By permanently genetically altering the vectors spreading disease (such as mosquitoes), gene drives could be used to prevent vector-borne diseases, including malaria, dengue fever, schistosomiasis, and Lyme disease, although they also come with ecological risks.14 — New methodologies using automation, machine learning, and proliferating biological data are enhancing discovery, throughput, and productivity in R&D. Biology and computing together are accelerating R&D, thereby addressing a productivity challenge. McKinsey analysis in 2017 found that the ratio of revenue to R&D spending in the biopharmaceutical industry hit a low point in productivity between 2008 and 2011.15 An explosion of biological data due to cheaper sequencing can be used by biotech companies and research institutes that increasingly are using robotic automation and sensors in labs that could increase throughput up to ten times.16 Further, advanced analytics, more powerful computational techniques, and AI can be leveraged to provide better insights during the R&D process. — Potential is growing for interfaces between biological systems and computers. A new generation of biomachine interfaces relies on close interaction between humans and computers. Such interfaces include neuroprosthetics that restore lost sensory functions (bionic vision) or enable signals from the brain to control physical movement of prosthetic or paralyzed limbs. Biocomputers that employ biology to mimic silicon, including the use of DNA to store data, are being researched. DNA is about one million times denser than hard-disk storage; technically, one kilogram of DNA could store the entirety of the world’s data (as of 2016).17 While these are early days, the scope and scale of these emerging capabilities could have a broad impact on economies and societies, touching multiple domains both directly and indirectly. These applications may change everything from the food we consume to textiles to the types of health treatments we receive and how we build our physical world. The potential value is vast. As noted, as much as 60 percent of the physical inputs to the global economy could be produced biologically, and even modest progress toward that 60 percent number could be transformative. Beyond the physical world, innovations could transform prevention, diagnostics, and treatment of disease. At least 45 percent of the global disease burden could be addressed with capabilities that are scientifically conceivable today, according to our analysis. Bio innovations, such as high-throughput screening, CRISPR, and machine learning for analyzing large and complex biological data, have also begun to shape R&D. We estimate that roughly 30 percent of private-sector R&D in major economies is in industries where biological data, biological inputs, or biological means of production could be used.18

Sign in to recut, update, or save this card.